Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(3.72)
# 551
Out of 5,049 analysts
46
Total ratings
51.16%
Success rate
9.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Maintains: Buy | $45 → $65 | $26.66 | +143.81% | 2 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $95 → $100 | $74.10 | +34.95% | 5 | Oct 30, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $25 → $18 | $12.32 | +46.10% | 4 | Oct 30, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Neutral | $60 → $55 | $51.84 | +6.10% | 2 | Oct 27, 2025 | |
| KYTX Kyverna Therapeutics | Maintains: Buy | $10 → $20 | $7.09 | +182.09% | 2 | Oct 27, 2025 | |
| ORKA Oruka Therapeutics | Maintains: Buy | $45 → $40 | $28.28 | +41.44% | 2 | Oct 27, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $15 → $13 | $8.42 | +54.39% | 3 | Oct 21, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $50 → $40 | $18.45 | +116.80% | 6 | Oct 21, 2025 | |
| LEGN Legend Biotech | Maintains: Buy | $75 → $60 | $32.37 | +85.36% | 1 | Oct 17, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $90 | $68.39 | +31.60% | 3 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $56.61 | +41.32% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $15.42 | +62.13% | 1 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $15.02 | +732.22% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.69 | +85.87% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $13.08 | +91.13% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $17.64 | -71.66% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $14.29 | +109.94% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.22 | +215.32% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $3.49 | -42.69% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $4.72 | +196.61% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $32.57 | +176.33% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.26 | +217.46% | 1 | Aug 11, 2025 |
Neurogene
Oct 31, 2025
Maintains: Buy
Price Target: $45 → $65
Current: $26.66
Upside: +143.81%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $95 → $100
Current: $74.10
Upside: +34.95%
Intellia Therapeutics
Oct 30, 2025
Maintains: Buy
Price Target: $25 → $18
Current: $12.32
Upside: +46.10%
BioMarin Pharmaceutical
Oct 27, 2025
Maintains: Neutral
Price Target: $60 → $55
Current: $51.84
Upside: +6.10%
Kyverna Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $7.09
Upside: +182.09%
Oruka Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $28.28
Upside: +41.44%
Lexeo Therapeutics
Oct 21, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $8.42
Upside: +54.39%
Summit Therapeutics
Oct 21, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $18.45
Upside: +116.80%
Legend Biotech
Oct 17, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $32.37
Upside: +85.36%
Halozyme Therapeutics
Oct 15, 2025
Reiterates: Buy
Price Target: $90
Current: $68.39
Upside: +31.60%
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $56.61
Upside: +41.32%
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $15.42
Upside: +62.13%
Sep 11, 2025
Reiterates: Buy
Price Target: $125
Current: $15.02
Upside: +732.22%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $2.69
Upside: +85.87%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $13.08
Upside: +91.13%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $17.64
Upside: -71.66%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $14.29
Upside: +109.94%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.22
Upside: +215.32%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.49
Upside: -42.69%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $4.72
Upside: +196.61%
Aug 13, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $32.57
Upside: +176.33%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.26
Upside: +217.46%